JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB199357

Anti-DR5 antibody [EPR19310]

5

(5 Reviews)

|

(19 Publications)

Rabbit Recombinant Monoclonal DR5 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 19 publications.

View Alternative Names

CD262, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186, TNFRSF10B, Tumor necrosis factor receptor superfamily member 10B, Death receptor 5, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2

9 Images
Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HT1080 (Human fibrosarcoma cell line) cells labeling DR5 with ab199357 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HT1080 cells. The nuclear counter stain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) at1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed (ab150120) at 1/1000 dilution (red).

The negative controls are as follows :
-ve control 1 : ab199357 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-DR5 antibody [EPR19310] (AB199357)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-DR5 antibody [EPR19310] (AB199357)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HCT 116 (Human colorectal carcinoma cell line) cells labeling DR5with ab199357 at 1/70 dilution (red) compared with aRabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-DR5 antibody [EPR19310] (AB199357)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HCT 116 (Human colorectal carcinoma cell line) cells labeling DR5 with ab199357 at 1/100 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous and cytoplasmic staining on HCT 116 cells. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed (ab150120) at 1/1000 dilution (red).

The negative controls are as follows :
-ve control 1 : ab199357 at 1/100 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)
  • IP

Supplier Data

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)

DR5 was immunoprecipitated from 0.35mg of HT1080 (Human fibrosarcoma cell line) treated with 5μM MG132 for 4 hour whole cell lysate with ab199357 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199357 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HT1080 treated with 5μM MG132 for 4 hour whole cell lysate, 10μg (Input).

Lane 2 : ab199357 IP in HT1080 treated with 5μM MG132 for 4 hour whole cell lysate.

Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab199357 in HT1080 treated with 5μM MG132 for 4 hour whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (ab199357)

Predicted band size: 47 kDa

false

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)
  • IP

Supplier Data

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (AB199357)

DR5 was immunoprecipitated from 0.35mg of HCT 116 (Human colorectal carcinoma cell line) whole cell lysate with ab199357 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab199357 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HCT 116 whole cell lysate, 10μg (Input).

Lane 2 : ab199357 IP in HCT 116 whole cell lysate.

Lane 3 : Rabbit IgG,monoclonal [EPR25A] - Isotype Control (ab172730) instead of ab199357 in HCT 116 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds.

All lanes:

Immunoprecipitation - Anti-DR5 antibody [EPR19310] (ab199357)

Predicted band size: 47 kDa

false

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1-2 : 3 minutes; Lane 3 : 10 seconds; Lane 4 : 8 seconds.

The expression profile is consistent with what has been described in the literature (PMID : 20515924; PMID : 16297203).

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Human melanoma lysate at 10 µg

Lane 2:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg

Lane 3:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg

Lane 4:

HT1080 (Human fibrosarcoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 47 kDa

Observed band size: 40 kDa,48 kDa

false

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Lab

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Lanes 1- 2 : Merged signal (red and green). Green - ab199357 observed at 47 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab199357 was shown to react with DR5 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab264922 (knockout cell lysate ab257748) was used. Wild-type HeLa and TNFRSF10B knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab199357 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

DR5 knockout HeLa cell lysate at 20 µg

Predicted band size: 47 kDa

Observed band size: 47 kDa

false

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Lab

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Lanes 1 - 2 : Merged signal (red and green). Green - ab199357 observed at 47 kDa. Red - loading control, ab9484, observed at 37 kDa.

ab199357 was shown to recognize DR5 in wild-type HAP1 cells as signal was lost at the expected MW in TNFRSF10B knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and TNFRSF10B knockout samples were subjected to SDS-PAGE. ab199357 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

TNFRSF10B knockout HAP1 whole cell lysate at 20 µg

Predicted band size: 47 kDa,72 kDa

Observed band size: 120 kDa,72 kDa

false

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)
  • WB

Supplier Data

Western blot - Anti-DR5 antibody [EPR19310] (AB199357)

Blocking/Dilution buffer : 5% NFDM/TBST.

Doxorubicin treatment elevated the expression of DR5 (PMID : 12496481; PMID : 11468181; PMID : 11090076). The expression profile is consistent with what has been described in the literature (PMID : 20515924; PMID : 16297203).

All lanes:

Western blot - Anti-DR5 antibody [EPR19310] (ab199357) at 1/1000 dilution

Lane 1:

Untreated HCT 116 (Human colorectal carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

HCT 116 (Human colorectal carcinoma cell line) treated with 0.5μM/ml doxorubicin for 24 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 47 kDa

Observed band size: 40 kDa,48 kDa

false

Exposure time: 8s

  • Carrier free

    Anti-DR5 antibody [EPR19310] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19310

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IP, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/70", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DR5 also known as Death Receptor 5 TRAIL-R2 or TNFRSF10B is a protein critical in apoptosis. It is a transmembrane receptor with a mass of approximately 54 kDa. Researchers find it expressed mostly in tissues such as lung colon and prostate. DR5 functions by binding to its ligand TRAIL triggering the extrinsic apoptotic pathway. Through this mechanism DR5 initiates a cascade of caspase activation that leads to cell death.
Biological function summary

DR5 plays a significant role in the regulation of apoptosis particularly in cancer cells. It is a component of the TRAIL receptor complex which includes several other death receptors like DR4. This complex formation allows DR5 to mediate apoptotic signals more efficiently. By controlling apoptosis DR5 helps maintain tissue homeostasis and prevents abnormal cell proliferation.

Pathways

DR5 is an important part of the TRAIL signaling pathway and the extrinsic apoptosis pathway. It connects with proteins like FADD and Caspase-8 essential in the apoptotic signaling cascade. By interacting with these proteins DR5 drives the progression of the apoptotic signal ensuring the removal of dysfunctional cells. Such pathways are vital for restraining tumor development and progression.

DR5 exhibits significant relevance to cancer and autoimmune diseases. Its ability to induce apoptosis through the TRAIL pathway keeps oncogenic transformations in check. In cancer DR5 often interfaces with other proteins like Bcl-2 which are involved in cell survival. Furthermore defects or aberrant expressions in DR5 have associations with autoimmune disorders where excessive cell death or survival contributes to disease pathology. DR5's role in these conditions makes it a promising target in therapeutic strategies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for the cytotoxic ligand TNFSF10/TRAIL (PubMed : 10549288). The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B. Essential for ER stress-induced apoptosis.
See full target information TNFRSF10B

Publications (19)

Recent publications for all applications. Explore the full list and refine your search

Avicenna journal of phytomedicine 14:64-77 PubMed38948179

2024

The modulating effects of astaxanthin on apoptosis in women with polycystic ovarian syndrome: A randomized clinical trial.

Applications

Unspecified application

Species

Unspecified reactive species

Masoome Jabarpour,Ashraf Aleyasin,Maryam Shabani Nashtaei,Mahshad Khodarahmian,Sara Lotfi,Fardin Amidi

Journal of biochemical and molecular toxicology 38:e23757 PubMed38937960

2024

Licochalcone D exhibits cytotoxicity in breast cancer cells and enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through upregulation of death receptor 5.

Applications

Unspecified application

Species

Unspecified reactive species

Yunyun Zhang,Linlin Wang,Chuxuan Dong,Yahui Zhuang,Gangping Hao,Fengze Wang

World journal of gastroenterology 29:1875-1898 PubMed37032730

2023

Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Xing Hu,Zhuo Liu,Zhen Zhang,Zhe Deng,Zhen Huang,Ting Feng,Qing-Hong Zhou,Si Mei,Chun Yi,Qing Zhou,Pu-Hua Zeng,Gang Pei,Sha Tian,Xue-Fei Tian

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 34:211-220 PubMed36511604

2022

Raw Lacquer Extract from Toxicodendron vernicifluum in Combination with ONC201 Enhances the Inhibitory Effects on Colorectal Cancer Cell Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhezhu Jin,Yongjun Jin

Bioengineered 12:11213-11224 PubMed34845969

2021

Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Qiang Zhou,Jianxia Yuan,Yi Liu,Yayun Wu

Cell reports 37:109953 PubMed34731630

2021

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Gururaj Shivange,Tanmoy Mondal,Evan Lyerly,Sanchita Bhatnagar,Charles N Landen,Shivani Reddy,Jonathan Kim,Britney Doan,Paula Riddle,Jogender Tushir-Singh

PloS one 16:e0246733 PubMed33661931

2021

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.

Applications

Unspecified application

Species

Unspecified reactive species

Korie A Grayson,Nidhi Jyotsana,Nerymar Ortiz-Otero,Michael R King

Molecular cancer therapeutics 20:833-845 PubMed33632873

2021

Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Korie A Grayson,Jacob M Hope,Wenjun Wang,Cynthia A Reinhart-King,Michael R King

Cytotechnology 73:63-70 PubMed33505114

2021

Encorafenib enhances TRAIL-induced apoptosis of colorectal cancer cells dependent on p53/PUMA signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenqing Sun,Zhigang Qiu,Bin Ma,Zhengkun Wang

Frontiers in pharmacology 11:522729 PubMed33071777

2020

Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qi Li,Qingsen Ran,Lidong Sun,Jie Yin,Ting Luo,Li Liu,Zheng Zhao,Qing Yang,Yujie Li,Ying Chen,Xiaogang Weng,Yajie Wang,Weiyan Cai,Xiaoxin Zhu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com